✦ LIBER ✦

Non-lipid effects of rosuvastatin–fenofibrate combination therapy in high-risk Asian patients with mixed hyperlipidemia

✍ Scribed by Sang-Hak Lee; Kyoung-Im Cho; Jang-Young Kim; Young Keun Ahn; Seung-Woon Rha; Yong-Jin Kim; Yun-Seok Choi; Si Wan Choi; Dong Woon Jeon; Pil-Ki Min; Dong-Ju Choi; Sang Hong Baek; Kwon Sam Kim; Young Sup Byun; Yangsoo Jang

Book ID: 118423996
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 473 KB
Volume: 221
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2011.12.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EFFECTS OF A FIXED COMBINATION OF FENOFI

EFFECTS OF A FIXED COMBINATION OF FENOFIBRATE AND PRAVASTATIN ON APOLIPOPROTEINS IN HIGH RISK PATIENTS WITH MIXED HYPERLIPIDEMIA

✍ Ducobu, J.; Farnier, M.; Fruchart, J.C. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

SAFETY AND EFFICACY OF LONG-TERM ADMINIS

SAFETY AND EFFICACY OF LONG-TERM ADMINISTRATION OF A FENOFIBRATE/PRAVASTATIN FIXED COMBINATION IN HIGH RISK PATIENTS WITH MIXED HYPERLIPIDEMIA

✍ Farnier, M.; Ducobu, J.; Bryniarski, L. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Effects of combination therapy with rosu

Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (≥2 mg/L)

✍ Christie M. Ballantyne; Michael H. Davidson; Carolyn M. Setze; Maureen T. Kelly 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 274 KB

Simultaneous Achievement of Optimal Lipi

Simultaneous Achievement of Optimal Lipid Levels with the Combination of Fenofibric Acid and Rosuvastatin in Patients with Mixed Dyslipidemia

✍ Michael H. Davidson; Peter H. Jones; Aditya Lele; Dawn M. Carlson; Carolyn M. Se 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 52 KB

Improvements in Lipid Ratios with the Co

Improvements in Lipid Ratios with the Combination of Rosuvastatin 5 mg and Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia

✍ Robert S. Rosenson; Maureen T. Kelly; Carolyn M. Setze; Alex Gold; Michael Cress 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 45 KB

Simultaneous Achievement of Optimal Lipi

Simultaneous Achievement of Optimal Lipid Targets with the Combination of Rosuvastatin 5 mg + Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia

✍ Robert S. Rosenson; Maureen T. Kelly; Carolyn M. Setze; Alex Gold; Michael Cress 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 55 KB